Cargando…

A Phase 1 Trial of pharmacologic interactions between transdermal selegiline and a 4-hour cocaine infusion

BACKGROUND: The selective MAO-B inhibitor selegiline has been evaluated in clinical trials as a potential medication for the treatment of cocaine dependence. This study evaluated the safety of and pharmacologic interactions between 7 days of transdermal selegiline dosed with patches (Selegiline Tran...

Descripción completa

Detalles Bibliográficos
Autores principales:	Harris, Debra S, Everhart, Thomas, Jacob, Peyton, Lin, Emil, Mendelson, John E, Jones, Reese T
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2731040/ https://www.ncbi.nlm.nih.gov/pubmed/19646280 http://dx.doi.org/10.1186/1472-6904-9-13

Ejemplares similares

The Clinical Pharmacology of Intranasal l-Methamphetamine
por: Mendelson, John E, et al.
Publicado: (2008)

Transdermal selegiline for the treatment of major depressive disorder
por: Lee, Kelly C, et al.
Publicado: (2007)

Physiologically Based Pharmacokinetic Modeling of Transdermal Selegiline and Its Metabolites for the Evaluation of Disposition Differences between Healthy and Special Populations
por: Puttrevu, Santosh Kumar, et al.
Publicado: (2020)

Selegiline: a molecule with innovative potential
por: Tábi, Tamás, et al.
Publicado: (2019)

Effects on Sperms’ Quality of Selegiline in Aged Rats
por: Kalász, Huba, et al.
Publicado: (2017)

Selegiline reduces daytime sleepiness in patients with Parkinson's disease
por: Gallazzi, Marco, et al.
Publicado: (2021)

Striking Neurochemical and Behavioral Differences in the Mode of Action of Selegiline and Rasagiline
por: Harsing, Laszlo G., et al.
Publicado: (2023)

Preclinical Herb–Drug Pharmacokinetic Interaction of Panax ginseng Extract and Selegiline in Freely Moving Rats
por: Yang, Ling, et al.
Publicado: (2020)

Adjuvant Potential of Selegiline in Attenuating Organ Dysfunction in Septic Rats with Peritonitis
por: Tsao, Cheng-Ming, et al.
Publicado: (2014)

Monitoring the Level of (14)C-Labelled Selegiline Following Oral Administration
por: Kalász, Huba, et al.
Publicado: (2017)

Effect of Combined Electroacupuncture and Selegiline Treatment in Alzheimer’s Disease: An Animal Model
por: Cai, Mudan, et al.
Publicado: (2020)

A Randomized Double-Blind Placebo-Controlled Phase III Trial of Selegiline Monotherapy for Early Parkinson Disease
por: Mizuno, Yoshikuni, et al.
Publicado: (2017)

Phase I and Pharmacokinetic Study of Paclitaxel by 24‐Hour Intravenous Infusion
por: Tamura, Tomohide, et al.
Publicado: (1994)

Neuroprotective Effects of Meloxicam and Selegiline in Scopolamine-Induced Cognitive Impairment and Oxidative Stress
por: Goverdhan, Puchchakayala, et al.
Publicado: (2012)

Comparison of Selegiline and Rasagiline Therapies in Parkinson Disease: A Real-life Study
por: Peretz, Chava, et al.
Publicado: (2016)

Improvement of Movement Disorder and Neurodevelopment under Selegiline in a CLTC‐Deficient Patient
por: Nardecchia, Francesca, et al.
Publicado: (2023)

Phase I trial and pharmacological study of a 3-hour paclitaxel infusion in children with refractory solid tumours: a SFOP study
por: Doz, F, et al.
Publicado: (2001)

Possible pharmacologic interactions caused by mixed infusion
por: Stögermüller, B, et al.
Publicado: (2008)

Effect of selegiline on neural stem cells differentiation: a possible role for neurotrophic factors
por: Hassanzadeh, Kambiz, et al.
Publicado: (2015)

Selegiline improves excessive daytime sleepiness in Parkinson's disease: an open-label observational study
por: Zhang, Jinru, et al.
Publicado: (2022)

Low Dose Betahistine in Combination With Selegiline Increases Cochlear Blood Flow in Guinea Pigs
por: Kloos, Benedikt, et al.
Publicado: (2022)

Efficacy and safety of selegiline for the treatment of Parkinson's disease: A systematic review and meta-analysis
por: Wang, Ke, et al.
Publicado: (2023)

Phase I Study of Paclitaxel by Three‐hour Infusion: Hypotension Just after Infusion Is One of the Major Dose‐limiting Toxicities
por: Tamura, Tomohide, et al.
Publicado: (1995)

Protective effect of selegiline on cigarette smoke-induced oxidative stress and inflammation in rat lungs in vivo
por: Cui, Yuting, et al.
Publicado: (2020)

Chronic Oral Selegiline Treatment Mitigates Age-Related Hearing Loss in BALB/c Mice
por: Szepesy, Judit, et al.
Publicado: (2021)

2438: Dose-dependent nature of cocaine infusions on cardiovascular hemodynamics
por: Carbone, Salvatore, et al.
Publicado: (2018)

Phase I trial with pharmacokinetics of CB10-277 given by 24 hours continuous infusion.
por: Foster, B. J., et al.
Publicado: (1993)

Selegiline remarkably improved stage 5 treatment-resistant major depressive disorder: a case report
por: Kitaichi, Yuji, et al.
Publicado: (2013)

Rotigotine in Combination with the MAO-B Inhibitor Selegiline in Early Parkinson’s Disease: A Post Hoc Analysis
por: Giladi, Nir, et al.
Publicado: (2016)

Monoamine oxidase B inhibitor, selegiline, reduces (18)F-THK5351 uptake in the human brain
por: Ng, Kok Pin, et al.
Publicado: (2017)

Mitigated Oxidative Stress and Cognitive Impairments in Transient Global Ischemia using Niosomal Selegiline-NBP delivery
por: Jafari, Bahareh, et al.
Publicado: (2022)

Neuroprotective Function of Rasagiline and Selegiline, Inhibitors of Type B Monoamine Oxidase, and Role of Monoamine Oxidases in Synucleinopathies
por: Naoi, Makoto, et al.
Publicado: (2022)

A phase I and pharmacokinetic study of didox administered by 36 hour infusion. The Cancer Research Campaign Phase I/II Clinical Trials Committee.
por: Carmichael, J., et al.
Publicado: (1990)

Effects of rasagiline, its metabolite aminoindan and selegiline on glutamate receptor mediated signalling in the rat hippocampus slice in vitro
por: Dimpfel, W, et al.
Publicado: (2011)

Accumulation of (123)I-Ioflupane Is a Useful Marker of the Efficacy of Selegiline Monotherapy in Drug-Naïve Parkinson’s Disease
por: Murakami, Hidetomo, et al.
Publicado: (2017)

Efficacy of rasagiline and selegiline in Parkinson’s disease: a head-to-head 3-year retrospective case–control study
por: Cereda, Emanuele, et al.
Publicado: (2017)

Genetic and Pharmacokinetic Determinants of Response to Transdermal Nicotine in White, Black and Asian Non-Smokers
por: Dempsey, Delia A., et al.
Publicado: (2013)

Crack Cocaine-Induced Cardiac Conduction Abnormalities Are Reversed by Sodium Bicarbonate Infusion
por: Miranda, Carlos Henrique, et al.
Publicado: (2013)

Cocaine
por: Jones, W. I.
Publicado: (1897)

Phase II trial of weekly 24-hour infusion of gemcitabine in patients with advanced gallbladder and biliary tract carcinoma
por: von Delius, Stefan, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_a0vglt7a4c6lpuk4pes449k0mm